Company profile

EVerZom

Revolutionizing healthcare with exosomes focusing on gastrointestinal, liver and kidney regeneration

Industry
Biotechnology
Employees
24
Headquarters
Paris, Ile-de-France
Founded
2019
LinkedIn followers
6,894
Office locations
1

EVerZom company summary

EVerZom is a company in the Biotechnology industry, headquartered in Paris, Ile-de-France, founded in 2019. On LinkedIn the company has around 24 employees and 6,894 followers. Its listed specialties include extracellular vesicles, exosomes, bioproduction, drug delivery, regenerative medecine.

What technology does EVerZom use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About EVerZom

EverZom is an exosome biotech company developing treatments for digestive tissue healing like Crohn's fistula and organ regeneration like the kidney and the liver. Founded in 2019, EverZom is positioned to become the leader of exosome therapeutics, the next wave of innovation for the biotech industry. Exosomes, small vesicles secreted by cells, are increasingly recognized as potent agents for intercellular communication and play a crucial role to treat a wide range of diseases. Winner of the European EIC Accelerator Program, EVerZom aims to be the upcoming pioneer in this new field. The company has successfully developed a multi-patented platform which enables exosome sourcing, generation, loading, and formulation to create proprietary programs and establish early-stage partnerships in the field of regenerative therapy and oncology.

Specialties

extracellular vesiclesexosomesbioproductiondrug deliveryregenerative medecinebiodrugscell culture

Where is EVerZom located?

EVerZom lists 1 location.

Paris, Ile-de-France, FRHQ
45, Rue des Saints-Pères

Compare companies similar to EVerZom

More companies in Biotechnology.

CompanyIndustryEmployeesFoundedHeadquarters
EVerZom
everzom.com
Biotechnology242019Paris, Ile-de-France
Regeneron
regeneron.com
Biotechnology17,234-Tarrytown, New York
Bharat Biotech
bharatbiotech.com
Biotechnology2,0351996Hyderabad, Telangana
Biotechnology1,0232008Pune, Maharashtra
Biotechnology393-Bethesda, MD
Biotechnology2,6502004Chennai, India
Biotechnology6922001Cambé, PR
Organica Biotech
organicabiotech.com
Biotechnology1462000Mumbai, Maharashtra
Biotechnology2172017South San Francisco, California
Biotechnology2271971Lagoa Santa, Minas Gerais
Biotechnology2432015London, United Kingdom

Frequently asked questions about EVerZom

What does EVerZom do?

EverZom is an exosome biotech company developing treatments for digestive tissue healing like Crohn's fistula and organ regeneration like the kidney and the liver. Founded in 2019, EverZom is positioned to become the leader of exosome therapeutics, the next wave of innovation for the biotech industry. Exosomes, small vesicles secreted by cells, are increasingly recognized as potent agents for intercellular communication and play a crucial role to treat a wide range of diseases. Winner of the European EIC Accelerator Program, EVerZom aims to be the upcoming pioneer in this new field. The company has successfully developed a multi-patented platform which enables exosome sourcing, generation, loading, and formulation to create proprietary programs and establish early-stage partnerships in the field of regenerative therapy and oncology.

How many employees does EVerZom have?

EVerZom has around 24 employees on LinkedIn.

Where is EVerZom headquartered?

EVerZom is headquartered in Paris, Ile-de-France.

When was EVerZom founded?

EVerZom was founded in 2019.

Build a lead list from companies like EVerZom

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.